Analog Devices (ADI) Rises As Market Takes a Dip: Key Facts

Analog Devices rose 1.13% to $433.11 while the S&P 500 fell 0.31%, the Dow fell 0.25% and the Nasdaq fell 1.38%. Ahead of its November 24, 2026 earnings release, consensus estimates call for quarterly EPS of $3.89 (+72.12% year over year) and revenue of $4.32 billion (+40.58%); the 30-day consensus EPS estimate has risen 0.31%, and ADI has a Zacks Rank of #2 (Buy).

Analysis

The setup is a high bar, not a fresh earnings signal: the large year-over-year growth figures sit alongside only a modest 30-day EPS estimate increase. That gap suggests investors should focus on whether estimates continue to move up—not on the headline growth rate, which may partly reflect comparison effects. Recent relative strength may also leave ADI more vulnerable to a guidance miss or merely in-line outlook into the November 24 report.

Valuation is not an obvious discount. A forward P/E near the peer-group level offers limited cushion if growth expectations roll over; the lower industry PEG cited in the article is not directly comparable without consistent growth assumptions. A key second-order risk is that inventory normalization or weaker industrial/communications demand could delay recovery across analog suppliers, including Texas Instruments, Microchip Technology, NXP Semiconductors, and STMicroelectronics. Conversely, sustained estimate upgrades and evidence of broad-based end-market recovery could support premium multiples and spill over to the group.

Near term, price action and estimate revisions matter more than the article’s bullish rank. Over 1–3 months, watch the earnings release for organic revenue breadth, order trends, gross-margin direction, and forward guidance. Over 6–18 months, the thesis depends on whether demand recovery converts to durable growth rather than a cyclical rebound. Falsifiers: successive estimate cuts, weaker-than-expected forward revenue or margin commentary, or a reversal of recent relative strength. No clear directional edge is established before those checks.

Key Decisions for Investors

• Do not chase the recent outperformance on this article alone. Treat the modest estimate revision as a watch signal, not confirmation of the forecast growth trajectory.
• For existing ADI exposure, consider reducing event concentration or using a defined-risk hedge into the November 24 report; reassess after guidance and order trends are available.
• Alert: track estimate revisions and reported revenue by end market, orders, and gross-margin guidance. A broad-based beat with upward forward revisions would strengthen the long case; estimate cuts or weaker guidance would invalidate it.
• Avoid a peer pair trade until relative valuation and end-market exposures are checked on a like-for-like basis; the article’s PEG comparison alone is insufficient.